KRAS and colorectal carcinoma: The most common co-mutations observed in non-CRC GI malignancies were TP53 (52%), CDKN2A (32%), CDKN2B (20%, detected in tissue only), ARID1A, SMAD4, KRAS (17%), and MTAP (16%, detected in tissue only).